PLAU and systemic sclerosis: Finally, miR-193b has been proposed as contributor of proliferative vasculopathy in SSc, because of its role regulating urokinase-type plasminogen activator (uPA), which was demonstrated by Iwamoto et al. in fibroblasts and skin biopsies from SSc patients [131].